Keystone Wealth Services’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Keystone Wealth Services's PFE Position: Q2 2026 in Review
Keystone Wealth Services reduced its Pfizer (PFE) stake by 14% in Q2 2026, selling an estimated $39.6K and leaving 9,081 shares worth $219K. The position accounts for 0.04% of the portfolio, ranked #302.
Keystone Wealth Services first reported a position in PFE in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.09M in Q4 2021. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Keystone Wealth Services held 9,081 shares of Pfizer worth $219K as of Q2 2026.
- Keystone Wealth Services sold 1,515 Pfizer shares in Q2 2026, an estimated $39.6K.
- Pfizer made up 0.04% of Keystone Wealth Services's portfolio in Q2 2026, its #302 holding.
- Keystone Wealth Services first reported a position in Pfizer in Q4 2021 and has held it in 19 quarters since.
- Keystone Wealth Services's Pfizer position peaked at $1.09M in Q4 2021.
- 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Keystone Wealth Services's 13F filing for Q2 2026, filed 5 Aug 2026.